The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels
- PMID: 37059250
- DOI: 10.1016/j.jep.2023.116499
The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels
Abstract
Ethnopharmacological relevance: The cause of irritable bowel syndrome (IBS), a functional gastrointestinal (GI) disorder, remains unclear. Banhasasim-tang (BHSST), a traditional herbal medicines mixture, mainly used to treat GI-related diseases, may have a potential in IBS treatment. IBS is characterized by abdominal pain as the main clinical symptom, which seriously affects the quality of life.
Aim of the study: We conducted a study to evaluate the effectiveness of BHSST and its mechanisms of action in treating IBS.
Materials and methods: We evaluated the efficacy of BHSST in a zymosan-induced diarrhea-predominant animal model of IBS. Electrophysiological methods were used to confirm modulation of transient receptor potential (TRP) and voltage-gated Na+ (NaV) ion channels, which are associated mechanisms of action.
Results: Oral administration of BHSST decreased colon length, increased stool scores, and increased colon weight. Weight loss was also minimized without affecting food intake. In mice administered with BHSST, the mucosal thickness was suppressed, making it similar to that of normal mice, and the degree of tumor necrosis factor-α was severely reduced. These effects were similar to those of the anti-inflammatory drug-sulfasalazine-and antidepressant-amitriptyline. Moreover, pain-related behaviors were substantially reduced. Additionally, BHSST inhibited TRPA1, NaV1.5, and NaV1.7 ion channels associated with IBS-mediated visceral hypersensitivity.
Conclusions: In summary, the findings suggest that BHSST has potential beneficial effects on IBS and diarrhea through the modulation of ion channels.
Keywords: Banhasasim-tang; Gastrointestinal disorders; Ion channels; Irritable bowel syndrome; Zymosan.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest No potential conflict of interest was reported by the authors.
Similar articles
-
Atractylodes macrocephala Koidz Alleviates Symptoms in Zymosan-Induced Irritable Bowel Syndrome Mouse Model through TRPV1, NaV1.5, and NaV1.7 Channel Modulation.Nutrients. 2024 May 29;16(11):1683. doi: 10.3390/nu16111683. Nutrients. 2024. PMID: 38892616 Free PMC article.
-
The Traditional Medicine Banhasasim-Tang Depolarizes Pacemaker Potentials of Cultured Interstitial Cells of Cajal through M3 Muscarinic and 5-HT3 Receptors in Murine Small Intestine.Digestion. 2020;101(5):536-551. doi: 10.1159/000501074. Epub 2019 Jun 11. Digestion. 2020. PMID: 31185476
-
Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.J Med Food. 2017 May;20(5):474-484. doi: 10.1089/jmf.2016.3844. Epub 2017 Apr 28. J Med Food. 2017. PMID: 28452565 Free PMC article.
-
Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.Adv Ther. 2020 Jan;37(1):83-96. doi: 10.1007/s12325-019-01116-z. Epub 2019 Nov 9. Adv Ther. 2020. PMID: 31707713 Review.
-
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.Drug Des Devel Ther. 2020 Apr 9;14:1391-1400. doi: 10.2147/DDDT.S216056. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32308371 Free PMC article. Review.
Cited by
-
Dual role of transient receptor potential ankyrin 1 in respiratory and gastrointestinal physiology: From molecular mechanisms to therapeutic targets.Front Physiol. 2024 Jul 3;15:1413902. doi: 10.3389/fphys.2024.1413902. eCollection 2024. Front Physiol. 2024. PMID: 39022308 Free PMC article. Review.
-
The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets.Int J Mol Sci. 2023 Jul 4;24(13):11074. doi: 10.3390/ijms241311074. Int J Mol Sci. 2023. PMID: 37446251 Free PMC article. Review.
-
Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5.Pharmaceuticals (Basel). 2024 Sep 4;17(9):1170. doi: 10.3390/ph17091170. Pharmaceuticals (Basel). 2024. PMID: 39338333 Free PMC article.
-
Atractylodes macrocephala Koidz Alleviates Symptoms in Zymosan-Induced Irritable Bowel Syndrome Mouse Model through TRPV1, NaV1.5, and NaV1.7 Channel Modulation.Nutrients. 2024 May 29;16(11):1683. doi: 10.3390/nu16111683. Nutrients. 2024. PMID: 38892616 Free PMC article.
-
Scutellaria baicalensis extracts alleviate zymosan-induced irritable bowel syndrome symptoms by modulating inflammation and ion channel activity.Anim Cells Syst (Seoul). 2025 May 20;29(1):360-371. doi: 10.1080/19768354.2025.2507327. eCollection 2025. Anim Cells Syst (Seoul). 2025. PMID: 40406596 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
